Williams, B, MacDonald, TM, Morant, SV, et al. Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies. Lancet Diabetes Endocrinol 2018; 6: 464–75—In this Article, the unit for aldosterone-to-renin ratio (ARR) was incorrect or missing in several places in the text and in figure 3. The unit for ARR should be pmol/mU. This correction has been made to the online version as of July 24, 2018.
. 2018 Aug;6(8):e16. doi: 10.1016/S2213-8587(18)30211-0
Correction to Lancet Diabetes Endocrinol 2018; 6: 464–75
© 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PMCID: PMC6130128 PMID: 30053988
This corrects the article "Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies" on page 464.
